Design of Red Fluorescence Ce-Based Carbon Dots of High and Balanced Multiple Functions against Alzheimer’s β-Amyloid Fibrillization
Source abstract
Abstract
The intricate pathophysiology of Alzheimer’s disease (AD), characterized by β-amyloid (Aβ) deposition, oxidative stress, and neuroinflammation, presents significant challenges for conventional single-target therapeutic approaches, thereby necessitating the development of innovative multifunctional theranostic strategies. Herein, red fluorescence cerium-based carbon dots (CCP-CD) were designed and synthesized via a one-step solvothermal method by purposely selecting curcumin (Cur) for inhibitory and anti-inflammatory effects, Ce(NO 3 ) 3 ·6H 2 O for enhancing antioxidant activity, and p-phenylenediamine (p-PD) for modulating fluorescence property as precursors. The as-prepared CCP-CD potently suppressed Aβ fibrillization and strongly eliminated multiple reactive oxygen species (ROS) (·OH, O 2 ·–, DPPH·) at low concentrations (1–10 μg/mL). Moreover, CCP-CD facilitates detection of Aβ plaques through a turn-on red fluorescence mechanism for both in vitro and in vivo imaging and quantification. In vitro assays showed that CCP-CD markedly attenuated Aβ-induced cytotoxicity and increased cell viability from ∼60 to 95%, as well as exhibited excellent anti-inflammatory effects by reducing the levels of TNF-α and IL-6 in BV-2 cells. In vivo experiments revealed that CCP-CD effectively suppressed Aβ plaque formation in the AD nematodes and prolonged the lifespan from 13 to 20 d. The unique structural characteristics of CCP-CD, including its conjugated aromatic framework, reversible Ce 3+ /Ce 4+ redox pair, and abundant O- and N-containing functional groups, facilitate balanced multiple therapeutic and diagnostic functions. The work has thus provided an exceptional nanoagent for detecting Aβ and fighting against Aβ-associated toxicities.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Nanocluster Synthesis and Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biochemical Engineering, School of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Frontier Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE)
Tianjin University
Funding
National Natural Science Foundation of China
References (60)
Show source-provided references
1. 10.1039/D4SC06762B10.1039/D4SC06762B ↗
2. 10.1039/C6CS00731G10.1039/C6CS00731G ↗
3. 10.1021/acschemneuro.1c0054410.1021/acschemneuro.1c00544 ↗
4. 10.1016/j.ccr.2023.21537510.1016/j.ccr.2023.215375 ↗
5. 10.1007/s00204-019-02538-y10.1007/s00204-019-02538-y ↗
6. 10.1016/j.arr.2022.10161910.1016/j.arr.2022.101619 ↗
7. Li W. B. · Adv. Mater. · 2024 · 36 · 240191810.1002/adma.202401918 ↗
8. 10.4103/1673-5374.35348410.4103/1673-5374.353484 ↗
9. 10.1021/acssuschemeng.1c0863810.1021/acssuschemeng.1c08638 ↗
10. 10.1016/j.nantod.2024.10217810.1016/j.nantod.2024.102178 ↗
11. 10.1002/smll.20241006310.1002/smll.202410063 ↗
12. 10.1039/D2TB02802F10.1039/D2TB02802F ↗
13. 10.1016/j.mattod.2019.05.00310.1016/j.mattod.2019.05.003 ↗
14. 10.1002/adma.20220015210.1002/adma.202200152 ↗
15. 10.1038/s41467-023-41489-y10.1038/s41467-023-41489-y ↗
16. 10.1016/j.mtbio.2021.10016710.1016/j.mtbio.2021.100167 ↗
17. 10.1016/j.snb.2023.13490110.1016/j.snb.2023.134901 ↗
18. 10.1016/j.tifs.2021.11.03210.1016/j.tifs.2021.11.032 ↗
19. 10.1016/j.jcis.2023.07.13210.1016/j.jcis.2023.07.132 ↗
20. 10.1002/adtp.20190005410.1002/adtp.201900054 ↗
21. 10.1002/smll.20220563410.1002/smll.202205634 ↗
22. 10.1016/j.snb.2024.13578510.1016/j.snb.2024.135785 ↗
23. 10.1016/j.actbio.2022.11.06310.1016/j.actbio.2022.11.063 ↗
24. 10.1016/j.colsurfb.2024.11390710.1016/j.colsurfb.2024.113907 ↗
25. 10.1016/j.cej.2021.13310110.1016/j.cej.2021.133101 ↗
26. 10.1016/j.apmt.2024.10213310.1016/j.apmt.2024.102133 ↗
27. 10.1016/j.cej.2021.13030110.1016/j.cej.2021.130301 ↗
28. 10.1088/1361-6528/ab12ef10.1088/1361-6528/ab12ef ↗
29. 10.1016/j.arr.2024.10239310.1016/j.arr.2024.102393 ↗
30. 10.1016/j.colsurfb.2023.11367610.1016/j.colsurfb.2023.113676 ↗
31. 10.3390/ph1404030910.3390/ph14040309 ↗
32. 10.1039/c1cp21156k10.1039/c1cp21156k ↗
33. 10.1021/ja804180610.1021/ja8041806 ↗
34. 10.1016/j.jcis.2024.05.19310.1016/j.jcis.2024.05.193 ↗
35. 10.1021/acsnano.4c1528310.1021/acsnano.4c15283 ↗
36. 10.1002/adfm.20241921910.1002/adfm.202419219 ↗
37. 10.1021/acsami.8b0094910.1021/acsami.8b00949 ↗
38. 10.1002/smll.20200280410.1002/smll.202002804 ↗
39. 10.1186/s12951-024-02360-410.1186/s12951-024-02360-4 ↗
40. 10.1002/adma.20170474010.1002/adma.201704740 ↗
41. 10.1016/j.carbon.2024.11920810.1016/j.carbon.2024.119208 ↗
42. 10.1021/acsami.2c1404510.1021/acsami.2c14045 ↗
43. 10.1002/smll.20220618010.1002/smll.202206180 ↗
44. 10.1016/j.carbon.2016.07.01910.1016/j.carbon.2016.07.019 ↗
45. 10.1016/j.trac.2018.03.01510.1016/j.trac.2018.03.015 ↗
46. 10.1039/D1TC06064C10.1039/D1TC06064C ↗
47. 10.1016/j.aca.2015.08.01110.1016/j.aca.2015.08.011 ↗
48. 10.1002/smll.20240316010.1002/smll.202403160 ↗
49. 10.1016/j.cej.2024.14852310.1016/j.cej.2024.148523 ↗
50. 10.1016/j.bioadv.2024.21395110.1016/j.bioadv.2024.213951 ↗
51. 10.1021/acsanm.2c0476410.1021/acsanm.2c04764 ↗
52. 10.1002/adfm.20230336310.1002/adfm.202303363 ↗
53. 10.1021/acsanm.4c0117510.1021/acsanm.4c01175 ↗
54. 10.1016/j.cej.2023.14824610.1016/j.cej.2023.148246 ↗
55. 10.1039/D2SC00253A10.1039/D2SC00253A ↗
56. 10.1039/D2NA00625A10.1039/D2NA00625A ↗
57. 10.1016/j.bbagen.2021.13006110.1016/j.bbagen.2021.130061 ↗
58. 10.1038/s41467-023-35828-210.1038/s41467-023-35828-2 ↗
59. 10.1002/anie.20191659110.1002/anie.201916591 ↗
60. 10.1021/acsnano.0c0607810.1021/acsnano.0c06078 ↗